Biotech startup HotSpot Therapeutics raises USD $100M

The money will help Boston-based cancer- and autoimmune disease-fighting startup HotSpot Therapeutics push forward its pipeline of therapeutics through 2024, its CEO tells Crunchbase News.

“What’s also super exciting for us is the mixture of health care venture attention as well as the technology sector,” said Geraldine Harriman, HotSpot co-founder and CSO. “It’s having investors that are typically technology-focused investors, and really seeing the value of that interface between technology and medicine.” 

More Updates :

This year has seen the number of new companies valued as decacorns double already, compared to 2020, marking the highest year on record for new startups valued at $10 billion or more. We take a look at the most active investors in these highly valued private companies, of which 30 new ones have been minted as decacorns year to date. The list leader? None other than Sequoia Capital.

Could the morning routine of the future include breathing in a mist or popping in a set of nosebuds to protect our lungs? As it turns out, a small but growing cohort of startup founders aim to commercialize wearable and individualized products to battle growing air pollution, allergens and, to some degree, even airborne diseases.

Series B typically represents the point in a startup’s lifecycle when it has proven technology or market traction and is on the cusp of major scaling. In a banner year for U.S. startup funding overall, we look at the state of Series B funding specifically and find companies are getting what looks like major capital to scale at this stage.

Sure, there’s an unprecedented amount of venture capital flowing toward startup founders, but founders need to look for an investor’s value beyond dollars, writes guest author Luisa Rubio Arribas. Beyond capital, here’s what she says you should seek in an investor—from an impressive professional network to a user base that can get companies brand recognition early on.

The fintech revolution continues to adopt many of the techniques and designs popularized by video games to address the challenges of usability and access, writes guest author Stephen Mathai-Davis. He argues that this trend represents more than just a dopamine booster—it also makes investing more accessible to a new generation of investors who are just getting started.

Sales organizations are still adjusting to changes that have upended the industry over the past 18 months. Now, they’re facing another dramatic shift: The Great Reshuffle. Alyssa Merwin, VP of Sales Solutions at LinkedIn, explains how The Great Reshuffle is a double-edged sword; creating potential risks and opportunities for sales leaders to focus on future-proofing their strategies.